Add-on Acquisition • Life Science

Novus Biologicals Acquires Imgenex

On October 30, 2013, Novus Biologicals acquired life science company Imgenex

Acquisition Context
  • This is Novus Biologicals’ 1st transaction in the Life Science sector.
  • This is Novus Biologicals’ 1st transaction in the United States.
  • This is Novus Biologicals’ 1st transaction in California.

Explore All 3116 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date October 30, 2013
Target Imgenex
Sector Life Science
Buyer(s) Novus Biologicals
Deal Type Add-on Acquisition

Target Company

Imgenex

San Diego, California, United States
Imgenex Corp. is a provider of specialized reagents for Life Science research with particular strength in the areas of Innate and Adaptive Immunity, Apoptosis and Cancer.
Explore More Deals

Browse All 215,262 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Novus Biologicals

Littleton, Colorado, United States

Category Company
Founded 1996
Sector Life Science
DESCRIPTION

Novus Biologicals LLC, is an e-commerce and life sciences company that develops, licenses and markets research materials to scientists in academic, corporate and government laboratories. Since 1996, Novus Biologicals has partnered with scientific researchers and third-party providers to develop a portfolio of more than 100,000 products. These research tools provide investigators with high-quality antibodies, proteins, kits and RNAi for the study of protein functions in disease in the key fields of cancer, neuroscience, and metabolic disorders.


Deal Context for Buyer #
Overall 1 of 1
Sector: Life Science 1 of 1
Type: Add-on Acquisition 1 of 1
State: California 1 of 1
Country: United States 1 of 1
Year: 2013 1 of 1